Roivant Sciences Ltd.

ROIV chart

Roivant Sciences Ltd. news

• SEC Form 4 filed by Roivant Sciences Ltd.

  Quantisnow · Oct 27, 6:28 PM EDT

• Taxes account for 116 shares of a 513-share director award at Roivant Sciences (ROIV).

  Stock Titan · Oct 27, 6:28 PM EDT

• Form 4 Roivant Sciences Ltd. For: Oct 23 Filed by: MOMTAZEE JAMES C

  StreetInsider · Oct 27, 6:23 PM EDT

• A director receives 383 Roivant Sciences (ROIV) shares, with 77 withheld for taxes.

  Stock Titan · Oct 27, 6:22 PM EDT

• Is Roivant Sciences (ROIV) Expensive As Phase 3 Brepocitinib Data Lifts Sentiment?

  Simply Wall Street · Oct 27, 7:22 AM EDT

• Roivant Sciences Ltd. (ROIV) Discusses Phase 3 Results for Brepocitinib in Non-Infectious Uveitis - Slideshow

  Seeking Alpha · Oct 24, 7:16 PM EDT

• Roivant Soars 8% as Brepocitinib Delivers “Phenomenal Results” in Two Phase 3 Uveitis Trials

  tikr.com · Oct 23, 1:25 PM EDT

• Roivant Sciences Ltd. Estimates – NASDAQ:ROIV

  TradingView · Oct 23, 9:49 AM EDT

• How Investors May Respond To Roivant Sciences (ROIV) Phase 3 Uveitis Win

  Simply Wall Street · Oct 23, 8:49 AM EDT

• Roivant Sciences(ROIV.US) Officer Sells US$7.02 Million in Common Stock

  Moomoo · Oct 22, 11:26 PM EDT

• Roivant Sciences Ltd Stock Price Live, Charts & News

  The Economic Times · Oct 22, 9:20 PM EDT

• Form 4 Roivant Sciences Ltd.: Eric Venker (President & Immunovant CEO) For: 20 October

  Investing.com Nigeria · Oct 22, 7:04 PM EDT

Roivant Sciences Ltd. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-10-21
• 8-K8-K2026-09-18
• 8-K8-K2026-09-08
• 8-K8-K2026-08-28
• 8-K8-K2026-08-27
• 10-Q10-Q2026-08-06
• 8-K8-K2026-08-06
• DEF 14ADEF 14A2026-07-29
• 10-K10-K2026-05-20
• 8-K8-K2026-05-20
• 8-K8-K2026-04-02
• 8-K/A8-K/A2026-03-23

About Roivant Sciences Ltd.

Ticker

ROIV (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

London

Incorporated in

Bermuda

Fiscal year end

March 31

SEC CIK

1635088

Frequently asked questions